Compare PDS & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDS | SPRY |
|---|---|---|
| Founded | 1951 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 918.1M | 823.2M |
| IPO Year | 1998 | 2020 |
| Metric | PDS | SPRY |
|---|---|---|
| Price | $94.53 | $7.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $122.33 | $40.00 |
| AVG Volume (30 Days) | 97.9K | ★ 1.7M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $84,278,000.00 |
| Revenue This Year | $5.66 | $87.40 |
| Revenue Next Year | $2.31 | $81.64 |
| P/E Ratio | $884.15 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $41.95 | $6.66 |
| 52 Week High | $103.80 | $18.63 |
| Indicator | PDS | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 35.06 |
| Support Level | $83.72 | $6.66 |
| Resistance Level | $103.13 | $8.61 |
| Average True Range (ATR) | 2.91 | 0.52 |
| MACD | 0.07 | -0.10 |
| Stochastic Oscillator | 46.28 | 14.57 |
Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.